360dx2h
Strong Immunodiagnostics Demand Drives 6 Percent Rise in Diasorin's Q3 Revenues
The company reported on Tuesday that its revenues jumped 8 percent in North America and Europe during the third quarter but fell slightly in the rest of the world.
360dx22h
Hologic Revenues Rise 5 Percent on Strength of Molecular Diagnostics Business
The firm reported a 13 percent jump in its non-COVID molecular diagnostics revenues year over year while its breast health and GYN Surgical business revenues rose 6 percent.
360dx22h
Tempus Expects $600M Ambry Genetics Acquisition to Accelerate Path to Cash Flow Breakeven
The firm's Q3 2024 revenues rose 33 percent year over year as both its genomics and data and services revenues increased in the double-digit percent range.
360dx23h
Digital Pathology Firm OptraScan Raises $30M in Series B Round
NEW YORK – Digital pathology company OptraScan announced on Tuesday that it has closed a $30 million Series B financing round. The round was led by molecular diagnostics firm Molbio Diagnostics. The ...
360dx23h
Antimicrobial Susceptibility Tech Firm iFast Diagnostics Raises $6.5M
NEW YORK — UK-based iFast Diagnostics said on Tuesday that it has raised $6.5 million in seed funding. The financing round was led by KHP Ventures and included EInk, Raw Ventures, and OKG Capital, as ...